<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03220503</url>
  </required_header>
  <id_info>
    <org_study_id>AinShamsMH Ysherbiny</org_study_id>
    <nct_id>NCT03220503</nct_id>
  </id_info>
  <brief_title>Effect of Endometrial Injury Before Frozen Embryo Transfer on Pregnancy Rate</brief_title>
  <official_title>Effect of Endometrial Injury Before Frozen Embryo Transfer on Pregnancy Rate</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams Maternity Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams Maternity Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Research Question:&#xD;
&#xD;
      In women undergoing frozen embryo transfer, does routine endometrial injury before frozen&#xD;
      embryo transfer increase clinical pregnancy rate?&#xD;
&#xD;
      Research Hypothesis:&#xD;
&#xD;
      (Null Hypothesis) In women undergoing frozen embryo transfer Routine endometrial injury&#xD;
      before frozen embryo transfer does not increase clinical pregnancy rate.&#xD;
&#xD;
      (Alternative Hypothesis) In women undergoing frozen embryo transfer, endometrial injury&#xD;
      before the transfer may increase pregnancy rate.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Suitable women will be invited to participate in the study then a signed and informed consent&#xD;
      will be obtained from them. When the patient's consent is obtained, they are to be included&#xD;
      into the study.&#xD;
&#xD;
      Data Collection:&#xD;
&#xD;
      During first visit, all patients will undergo complete clinical examination and detailed&#xD;
      medical history will be obtained. Each patient will have a Case Record Form (CRF) in which&#xD;
      the following data will be recorded.&#xD;
&#xD;
        -  Patient number (according to the randomization schedule).&#xD;
&#xD;
        -  Age, BMI.&#xD;
&#xD;
        -  Past medical and surgical history.&#xD;
&#xD;
        -  Duration of infertility.&#xD;
&#xD;
      Procedure:&#xD;
&#xD;
      Endometrial injury:&#xD;
&#xD;
      A single induced injury will be done on the posterior endometrium on day 7 of the transfer&#xD;
      cycle by using modified Cook catheter Protocol for vitrification Embryos will first loaded&#xD;
      with equilibrium solution containing7.5% ethylene glycol (EG) and 7.5% dimethyl sulphoxide&#xD;
      (DSMO) (Sigma-Aldrich) for 5-10 minute at room temperature and then with vitrification&#xD;
      solution containing 15% EG, 15% DSMO and 0.5 mol/L sucrose for 50-60 seconds at room&#xD;
      temperature. After observed cellular shrinkage, embryos will quickly stored in liquid&#xD;
      nitrogen (LN) for at least 2 months. At warming, embryos will removed from LN and embryos&#xD;
      will exposed to thawing solution containing sucrose at 37°C temperature for 50-60 seconds and&#xD;
      then embryos will sequentially incubated in diluents solutions before being transferred .&#xD;
&#xD;
      Evaluation and transfer of thawed embryos After thawing, each embryo will evaluated twice,&#xD;
      once immediately for the number of surviving blastomeres and again after 18 hours post-thaw&#xD;
      in vitro culture for assessing of mitosis and number of blastomeres. Embryos will considered&#xD;
      survived if &gt;50% of each blastomere are intact and selected for intrauterine transfer&#xD;
      (Depending on patients' embryos, 2 or 3 embryos will transferred).&#xD;
&#xD;
      Embryos will classified as fully intact or excellent morphology (100% cells survived with&#xD;
      &lt;10% fragmentation) or good morphology (100% cells survived with 10%-20% fragmentation),&#xD;
      partially damaged or poor morphology (≥50% cells survived with or without any fragmentation)&#xD;
      and Degenerated embryos (&lt;50% cells survived) .Only fully intact and partially damaged&#xD;
      embryos will transferred. Degenerated or arrested embryos will not transferred.&#xD;
&#xD;
      Protocol of endometrial preparation before Frozen Embryo Transfer (FET) :&#xD;
&#xD;
      There are different protocols for FET cycles. That is true for both &quot;natural cycle&quot; FETs and&#xD;
      for &quot;hormone replacement cycle&quot; frozen-thawed embryo transfers. We will use hormone&#xD;
      replacement cycles because they have better success rates. However, some clinics offer a&#xD;
      natural cycle FET approach. Success rates are higher with hormone replacement, or&#xD;
      &quot;controlled&quot; FET cycles.&#xD;
&#xD;
      Medicines and Drugs in a Frozen Embryo Transfer FET Cycle&#xD;
&#xD;
        1. Gonadotropin-Releasing Hormone agonist (such as Lupron) will be given, either midluteal&#xD;
           (day 21) or overlapping with a birth control pill.&#xD;
&#xD;
        2. Down-regulation will be confirmed by ultrasound and blood tests.&#xD;
&#xD;
        3. Estradiol valerate 2 mg twice daily (orally) will start after the period. This dose may&#xD;
           need to be increased after monitoring of the uterine lining thickness.&#xD;
&#xD;
        4. When the endometrium has a &quot;good&quot; thickness( &gt; 8 mm), progesterone will be started&#xD;
           (intramuscular shots, or a vaginal product).&#xD;
&#xD;
        5. Embryo transfer will be planned for 3-6 days later - depending on the stage of&#xD;
           development of the embryos to be transferred.&#xD;
&#xD;
        6. Estrogen and progesterone will be continued in the luteal phase.&#xD;
&#xD;
        7. Pregnancy testing will be done 9-14 days after transfer - depending on the stage of&#xD;
           development of the embryos replaced and the preferences of the fertility clinic.&#xD;
&#xD;
        8. If pregnant, estrogen and progesterone will be continued until about 10-15 weeks of&#xD;
           pregnancy and then weaned off.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">March 8, 2017</start_date>
  <completion_date type="Anticipated">October 1, 2017</completion_date>
  <primary_completion_date type="Anticipated">September 9, 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Chemical pregnancy rate</measure>
    <time_frame>two weeks after frozen embryo transfer</time_frame>
    <description>serum Beta -Human Chorionic Gonadotropin positive</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical pregnancy rate</measure>
    <time_frame>four weeks after frozen embryo transfer</time_frame>
    <description>appearance of gestational sac on trans-vaginal ultrasound</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>Group (A)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>consists of 25 patients will receive frozen embryo with endometrial scratching on day 7 of transfer cycle.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group (B)</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>consists of 25 patients will receive frozen embryo without endometrial scratching as control group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>endometrial injury</intervention_name>
    <description>single induced injury will be done on the posterior endometrium on day 7 of the transfer cycle by using modified Cook catheter.</description>
    <arm_group_label>Group (A)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All infertile women have high quality frozen embryos.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of endocrine disease such as: diabetes; Hyperthyroidism and&#xD;
             Hyperprolactinemia.&#xD;
&#xD;
          -  History of hysteroscopic surgery due to intrauterine adhesions.&#xD;
&#xD;
          -  History of cardiovascular, renal or liver disease .&#xD;
&#xD;
          -  History of stroke or myocardial infarction.&#xD;
&#xD;
          -  Poor quality embryos.&#xD;
&#xD;
          -  Alcohol or Substance abuse.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adel Sh Salah El-Din, Ass. Prof.</last_name>
    <role>Study Director</role>
    <affiliation>Ain Shams University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohammed A Faris, Lecturer</last_name>
    <role>Study Director</role>
    <affiliation>Ain Shams University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohamed E Shawky, Lecturer</last_name>
    <role>Study Director</role>
    <affiliation>Ain Shams University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yasser Sherbiny, invistgator</last_name>
    <phone>+201008961189</phone>
    <email>drysherbiny89@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>ART unit - Ain Shams university Matrnity Hospital</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>yasser sherbiny, invistgator</last_name>
      <phone>+201008961189</phone>
      <email>drysherbiny89@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <study_first_submitted>June 15, 2017</study_first_submitted>
  <study_first_submitted_qc>July 16, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 18, 2017</study_first_posted>
  <last_update_submitted>July 16, 2017</last_update_submitted>
  <last_update_submitted_qc>July 16, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams Maternity Hospital</investigator_affiliation>
    <investigator_full_name>Yasser sherbiny</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

